10-Q: AXT Reports Mixed Q3, Faces Trade Headwinds & Nasdaq Scrutiny

AXT, Inc. reported an 18.2% revenue increase in Q3 2025 driven by substrate demand, but nine-month results show significant declines and ongoing geopolitical and legal challenges.

Summary

• Revenue for the three months ended September 30, 2025, increased by 18.2% to $28.0 million, compared to $23.6 million in the same period of 2024.
• Substrate revenue rose 41.7% to $21.3 million in Q3 2025, primarily due to higher demand for InP wafer substrates for data center applications and passive optical networks, following additional export approvals from China.
• Raw materials sales decreased by 22.5% to $6.7 million in Q3 2025, attributed to weaker market demand for refined gallium and pBN crucibles.
• Gross profit for Q3 2025 increased by 9.5% to $6.2 million, though the gross profit margin slightly decreased to 22.3% from 24.0% year-over-year.
• Net loss attributable to AXT, Inc. improved to $(1.9) million in Q3 2025 from $(2.9) million in Q3 2024.
• For the nine months ended September 30, 2025, total revenue decreased by 12.1% to $65.3 million from $74.3 million in the prior year period.
• Nine-month gross profit significantly declined by 67.0% to $6.4 million, with the gross profit margin falling to 9.8% from 26.2% in the prior year period, primarily due to unfavorable yields in gallium arsenide production and export restrictions on indium phosphide.
• Net loss attributable to AXT, Inc. for the nine months ended September 30, 2025, worsened to $(17.7) million from $(6.5) million in the prior year period.
• North America revenue decreased by 94.5% in Q3 2025 and 70.5% for the nine months ended September 30, 2025, largely due to China's export restrictions on InP and GaAs wafer substrates and lower demand for pBN crucibles.
• Cash and cash equivalents were $23.1 million as of September 30, 2025, with restricted cash of $8.1 million, resulting in a net decrease of $2.6 million in total cash and restricted cash for the nine-month period.
• Short-term loans increased to $61.5 million as of September 30, 2025, from $47.3 million at December 31, 2024.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative. While Q3 showed some revenue and net loss improvement, the nine-month financial performance is significantly worse, particularly the sharp decline in gross profit and increased net loss. Ongoing geopolitical tensions, export restrictions, and pending legal issues create substantial uncertainty and risk. Nasdaq non-compliance adds a governance concern, though a cure period is in place. The potential for a capital raise indicates a need for funding despite current liquidity.

Positives

• Q3 2025 revenue increased by 18.2% year-over-year, reaching $28.0 million.
• Substrate revenue saw a substantial 41.7% increase in Q3 2025, driven by higher demand for InP wafer substrates for data center and passive optical network applications.
• The company received initial export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates to certain customers in Europe, Japan, the UK, and Canada.
• Net loss attributable to AXT, Inc. improved in Q3 2025 to $(1.9) million from $(2.9) million in Q3 2024.
• Research and development expenses decreased significantly by 70.5% in Q3 2025 and 36.1% for the nine months ended September 30, 2025, due to one-time benefits of certain materials.
• The maximum number of at-risk performance shares for the CEO and CFO became eligible to vest for fiscal year 2024, following a certified year-over-year annual revenue growth rate of 200%.
• Net decrease in cash, restricted cash, and cash equivalents was smaller in the nine months ended September 30, 2025, compared to the same period in 2024.

Negatives

• Total revenue for the nine months ended September 30, 2025, decreased by 12.1% year-over-year.
• Gross profit for the nine months ended September 30, 2025, plummeted by 67.0% to $6.4 million, with the gross margin falling from 26.2% to 9.8%.
• Significant unfavorable yields in gallium arsenide production lines negatively impacted gross profit for the nine-month period.
• Export restrictions imposed by China on indium phosphide negatively impacted product mix and total substrate revenue for the nine months ended September 30, 2025.
• Raw materials sales decreased by 22.5% in Q3 2025 and 4.2% for the nine months ended September 30, 2025, due to weaker market demand.
• North America revenue declined sharply by 94.5% in Q3 2025 and 70.5% for the nine months ended September 30, 2025, primarily due to China's export restrictions and tariffs.
• Net loss attributable to AXT, Inc. worsened for the nine months ended September 30, 2025, to $(17.7) million from $(6.5) million in the prior year period.
• Net cash used in operating activities increased to $(17.1) million for the nine months ended September 30, 2025, from $(13.4) million in the prior year period.
• Short-term loans increased by $14.3 million to $61.5 million as of September 30, 2025.
• The company is not compliant with Nasdaq Listing Rule 5605(c)(2)(A) due to its Audit Committee having only two independent directors after a director's passing and the appointment of a non-independent director.
• Government grants, included in other income, net, decreased significantly to $0.1 million in Q3 2025 from $0.5 million in Q3 2024, and to $0.6 million in 9M 2025 from $1.9 million in 9M 2024.
• An impairment charge of $145,000 was recognized for the Jia Mei investment during the nine months ended September 30, 2025.

Risks

• Global economic and political conditions, including trade tariffs, import-export restrictions, and other restrictions, may negatively impact the business and financial results.
• The PRC central government may intervene in or influence PRC operations at any time, and rules and regulations in China can change quickly with little advance notice.
• Uncertainty exists regarding the ability to obtain necessary permissions or approvals from the CSRC or other PRC central government authorities for public offerings of securities in the U.S., or if applicable laws, regulations, or interpretations change.
• The NASDAQ stock price is volatile and could decline due to unpredictable fluctuations in operating results, changes in end markets, and global trends.
• The company faces ongoing litigation and legal proceedings (shareholder class action, derivative lawsuit) which could adversely affect its business, financial condition, results of operations, or cash flows.
• Changes in China's political, social, regulatory, or economic environments may affect financial performance.
• The Chinese central government's efforts to reduce air pollution and other environmental pollution can impact manufacturing, including intermittent mandatory shutdowns, which may result in declines in gross margins.
• Escalating and volatile trade tariffs, import restrictions, export restrictions, Chinese regulations, or other trade barriers may materially harm the business.
• Restrictions on freight and transportation routes and on ports of entry and departure in China could result in shipping delays or increased costs.
• International operations are exposed to potential adverse tax consequences in China, including transfer pricing challenges and VAT assessments.
• Gross margin has fluctuated historically and may decline due to factors such as product mix, unit volume, yields, raw material costs, tariffs, and manufacturing efficiencies.
• The proposed Tongmei IPO on the STAR Market in China could fail, potentially leading to investor disappointment and failure to secure sufficient capital, and a decline in stock price.
• The terms of the private equity raised by Tongmei grant each investor a right of redemption if the IPO fails, potentially requiring the company to disgorge approximately $49 million.
• Defects in products could diminish demand, lead to product rejections, compensation costs, and possible disqualification from customers.
• Difficulties in accurately estimating market demand could result in over-investing in inventory, equipment, and capacity expansion or losing market share.
• Attracting and retaining tier one customers requires success in research and development programs to meet difficult product specifications.
• The company is subject to foreign exchange gains and losses that may materially impact its condensed consolidated statements of operations.
• Joint venture raw material companies in China bring certain risks, including operational problems, environmental orders, and potential litigation.
• A significant portion of revenue is derived from international sales, and the ability to sustain and increase these sales involves significant risks.
• Silicon-based technologies could replace specialty material-based substrates for certain applications, decreasing demand for the company's products.
• The loss of one or more tier one substrate customers would significantly hurt operating results.
• Strategic investments in raw materials suppliers may not be successful and could result in the loss of all or part of the investment.
• Damage to facilities from occurrences like fire, explosion, power outage, or natural disaster could prevent product manufacturing.
• Substrate products have a long qualification cycle, making it difficult to forecast revenue from new customers or products.
• The cyclical nature of the semiconductor industry may limit the ability to maintain or increase net sales and operating results during industry downturns.
• Dependence on the continuing efforts of senior management and other key personnel, with potential harm if they are lost or not successfully recruited.
• Ineffective inventory management could lead to excess or obsolete inventory charges.
• Terrorist threats and actions on the general economy could decrease revenue.
• Uncertainty regarding United States foreign policy, particularly with regards to China, could disrupt business.
• Financial market volatility and adverse changes in the domestic, global, political, and economic environment could have a significant adverse impact.
• PRC central government may exert more control over overseas offerings and/or foreign investment in China-based issuers.
• PRC subsidiaries and joint ventures are subject to data security oversight by the Cyberspace Administration of China (CAC).
• Power shortages in China could lead to temporary closures of operations.
• Although the audit report is prepared by a fully inspected PCAOB firm, there is no guarantee future reports will be, potentially leading to delisting risks under the HFCA Act.
• Utilization of cash balances for various initiatives could lead to a decline in existing cash, and additional capital may not be available on acceptable terms.
• Unpredictable fluctuations in operating results could disappoint analysts or investors, causing stock price decline.
• Failure to meet public guidance on operating and financial results could cause stock price decline.
• Anti-takeover measures may make it more difficult for a third party to acquire the company.
• Non-compliance with Nasdaq listing requirements could lead to delisting.
• Ability to use net operating loss carryforwards and certain other tax attributes may be limited.
• Intellectual property infringement claims may be costly and divert management attention.
• Failure to comply with environmental and safety regulations could result in significant fines or forced cessation of operations.
• Potential for suits for personal injuries caused by hazardous materials.

Future Outlook

The company anticipates that the growth of AI applications will increase the need for high-speed data transfer, potentially leading to increased demand for InP substrates. Tongmei hopes to complete its IPO on the STAR Market in the coming months, pending review and approval by the CSRC and other authorities. Management expects mandatory factory shutdowns due to air pollution in China to occur in the future and anticipates similar cycles of strong demand followed by lower demand for various InP, GaAs, or Ge substrates. The company reasonably expects to receive export permits for indium phosphide shipments to the U.S., though the timing remains uncertain. Management believes it has adequate cash and investments to meet operating needs and capital expenditures over the next 12 months and has filed a shelf registration statement for up to $100 million for general corporate purposes. The company does not currently plan to repurchase additional shares or distribute earnings to investors under its corporate structure.

Management Comments

• Morris S. Young, CEO, and Gary L. Fischer, CFO, certified that the quarterly report on Form 10-Q does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made not misleading.
• Management believes the claims in the shareholder class action and derivative lawsuit are meritless and intends to vigorously defend against them.
• Management believes that cooperation agreements with Chinese local governments are normal, customary, and usual, and that future valuation is flexible.
• Management believes its success in the relocation of manufacturing lines and ability to add capacity in the future gives competitive advantages.
• Management believes a new level of technological sophistication in manufacturing capabilities is enabling support for major trends likely to drive demand for products.
• Management believes its vertically integrated supply chain strategy will be even more advantageous in the event of industry-wide supply shortages.
• Management believes Tongmei has grown into a company that will be an attractive offering on the STAR Market.
• Management believes indium phosphide is rarely used in military applications and reasonably expects that export permits to ship indium phosphide substrates to the U.S. will be granted.

Industry Context

The semiconductor industry is characterized by its highly cyclical nature, experiencing periods of significant economic downturns, production overcapacity, and inventory corrections. The company's products, high-performance compound and single element semiconductor substrates, are used in specialized applications where silicon cannot meet performance requirements, such as broadband, fiber optics, 5G infrastructure, and data centers. The growth of AI applications is expected to drive increased demand for high-speed data transfer, potentially benefiting InP substrate demand. However, the industry faces intense competition from other substrate manufacturers (e.g., Sumitomo, JX, Freiberger) and from silicon-based technologies (e.g., SOI) that offer lower costs. Geopolitical tensions between China and the U.S., including escalating tariffs and export controls, are creating an unstable business environment, encouraging self-sufficiency and domestic production in China, and causing supply chain disruptions. The Chinese government's increasing focus on environmental controls and air pollution also impacts manufacturing operations through potential mandatory shutdowns. Global economic uncertainties, high inflation, and interest rates further contribute to a challenging market landscape.

Comparison to Industry Standards

• The filing mentions competitors such as Sumitomo, JX, Freiberger, Umicore, Vital, and CCTC in the wafer substrate market, and Qorvo and Skyworks for alternative materials, but does not provide specific comparable financial or operational results against these companies.
• The company's gross margin of 9.8% for the nine months ended September 30, 2025, is significantly lower than its 26.2% in the prior year, indicating underperformance relative to its own historical standards, likely due to industry downturns and specific operational challenges like unfavorable GaAs yields and InP export restrictions.
• The company's experience with silicon-on-insulator (SOI) technology replacing GaAs substrates in mobile phones highlights a competitive threat where lower-cost alternatives can gain market acceptance, a trend common across the broader semiconductor industry.

Management Changes

Corporate Governance

Legal Proceedings

• A putative shareholder class action complaint was filed on May 6, 2024, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The court granted a motion to dismiss with leave to amend on May 28, 2025. A second amended complaint was filed on June 27, 2025, and defendants moved to dismiss again on July 11, 2025, with the motion currently pending.
• A derivative lawsuit was filed on August 22, 2024, by an alleged shareholder against current and former directors and officers, alleging breach of fiduciary duties. The court granted the motion to dismiss on March 17, 2025, for failure to make a pre-suit demand and failure to state a claim. The plaintiff filed a notice of appeal on May 13, 2025.

Related Party Transactions

• ChaoYang XinMei, a consolidated subsidiary, received funding from a minority investor and Tongmei (a related party) in September and October 2021, and December 2021 and January 2022.
• In April 2022, Tongmei entered into a capital increase agreement with minority investors to further invest in ChaoYang XinMei, with Tongmei and minority investors providing funding in April, May, and July 2022.
• In September 2022, ChaoYang LiMei, a consolidated subsidiary, sold land and buildings to ChaoYang KaiMei, an equity investment entity, for $1.5 million, which was paid in January 2023.
• Executive officers retain board seats on the board of directors of the companies in which the company has invested in its PRC joint ventures.
• For the nine months ended September 30, 2025, aggregate dividends of $0.9 million were paid to the company (directly or to an intermediate entity) by PRC subsidiaries and PRC raw material joint ventures.
• No transfers, dividends, or distributions were made between the company and its PRC subsidiaries, or to investors, for the nine months ended September 30, 2025, except for the settlement of amounts owed under transfer pricing arrangements in the ordinary course of business.

Stakeholder Impact

• Shareholders face potential stock price volatility due to unpredictable operating results, geopolitical tensions, and ongoing legal proceedings.
• Shareholders are exposed to the risk of delisting from Nasdaq if the company fails to regain compliance with Audit Committee independence requirements.
• Employees may be impacted by potential workforce reductions, though not explicitly stated as current, it is mentioned as a risk factor.
• Customers may experience supply chain disruptions and delays due to China's export controls and U.S. tariffs, particularly for InP and GaAs substrates.
• Customers may face product quality issues, potentially leading to returns, reduced orders, or disqualification if the company fails to meet specifications.
• Suppliers face risks related to the company's dependence on single or limited sources for critical raw materials and parts, potentially leading to higher costs if alternative sourcing is required.
• Creditors are impacted by the increase in short-term loans and the collateralization of certain loans, indicating increased financial leverage.

Next Steps

• Regain compliance with Nasdaq Listing Rule 5605(c)(2)(A) regarding Audit Committee composition by appointing a new independent director by July 11, 2026 (or January 7, 2026, if the next annual meeting is held before then).
• Continue to monitor and follow up on the status of applications for indium phosphide export permits to the U.S.
• Continue to pursue Tongmei's IPO on the STAR Market, subject to review and approval by the CSRC and other authorities.
• Vigorously defend against the pending shareholder class action and derivative lawsuits.
• Utilize proceeds from the shelf registration statement for working capital, capital expenditures, and other general corporate purposes.

Key Dates

Recommendation

The company's Q3 2025 results show some positive momentum with increased revenue and improved net loss, particularly in the substrate segment due to new export approvals. However, the nine-month performance reveals significant challenges, including a substantial decline in gross profit and a worsening net loss, primarily driven by unfavorable GaAs yields and ongoing export restrictions. Geopolitical tensions, particularly concerning U.S. export permits for InP and GaAs, remain a major overhang, creating considerable uncertainty. The Nasdaq non-compliance, while having a cure period, adds a governance risk. The pending shareholder class action and derivative lawsuit also present potential liabilities and distractions. While the company has a shelf registration for potential capital raises, indicating flexibility, the overall environment is highly volatile. A seasoned investor would likely hold to observe how the export permit situation evolves, if the gross margin can recover from its nine-month low, and the outcomes of the legal and governance issues before making a more definitive investment decision.

Keywords

Semiconductor substrates, Indium phosphide, Gallium arsenide, Germanium wafers, Raw materials, China export controls, Trade tariffs, STAR Market IPO, AXT Inc, Compound semiconductors, Data center connectivity, 5G infrastructure, Optoelectronics, Supply chain, Financial results, SEC filing, Nasdaq compliance, Legal proceedings